Analyst Scoreboard: 4 Ratings For LeMaitre Vascular
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for LeMaitre Vascular (NASDAQ:LMAT) over the past three months, with a recent average price target of $95.0, marking a 14.91% increase from the previous target. The company's financial performance shows strong profitability and effective cost management, despite lagging revenue growth compared to peers.
October 15, 2024 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LeMaitre Vascular has received mixed analyst ratings with a new average price target of $95.0, indicating a potential 14.91% upside. The company's strong profitability and effective cost management are positive, but its revenue growth lags behind industry peers.
The increase in the average price target to $95.0 suggests a positive outlook from analysts, despite mixed ratings. The company's strong profitability metrics, such as net margin and ROE, are favorable indicators. However, the lag in revenue growth compared to peers may temper enthusiasm. Overall, the positive price target revision and strong financial health suggest a likely short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100